The Cosmetics Testing News

Follow the testing news dedicated to innovations and trends in the evaluation of active, ingredients, cosmetics and medical devices

SkinAbs®, the new system for percutaneous penetration studies by Alphenyx

21 March 2018

Alphenyx is a biotech company based in Marseille, within the Grand Luminy Technopole.

We are specialized in sourcing and custom-made transformation of human tissues for research, and offer a variety of products, such as living skin explants, dermatomed skin disks or primary cells. We therefore provide alternative solutions to animal testing for pre-clinical studies of new drugs and predictive evaluation in cosmetics. Developing new products to better respond to our customer experimental constraints, we are pleased to present our new model “SkinAbs®”.

SkinAbs® is a new ready to use system for percutaneous penetration studies, adaptable to any Franz’s Cell system. This system is characterized by the association of a dermatomed skin disc (or a full skin disc on demand) and a silicone ring, acting as a seal, allowing faster handling. SkinAbs®, as all Alphenyx dermatomed skin discs, undergoes a strict quality control for thickness to guarantee homogenous discs and an optimal reproducibility.

For more information, we invite you to meet us at our booth during the Perspectives in Percutaneous Penetration Conference 2018 from the 4th to the 6th April 2018 in la Grande Motte or to contact us: enquiries@alphenyx.com.

Partie 1.2.2

Technopole Grand Luminy (Pépinière Biotech), Case 922

163 avenue de Luminy

13288 Marseille Cedex 09, France

0033(0)4.86.94.85.19

www.alphenyx.com